Clinical Trials on Cutaneous T-Cell Lymphoma Refractory
Total 7917 results
-
M.D. Anderson Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Mycosis Fungoides | Lymphoma, Primary Cutaneous Anaplastic Large Cell | CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma | Lymphomatoid Papulosis | Skin Lymphoma | Cutaneous Lymphomas | Hematologic DisorderUnited States
-
Acrotech Biopharma Inc.CompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, Italy
-
UNC Lineberger Comprehensive Cancer CenterStand Up To Cancer; University Cancer Research Fund at Lineberger Comprehensive...RecruitingNeoplasms | Immune System Diseases | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Mycosis Fungoides | Sezary Syndrome | Cutaneous T Cell Lymphoma | Gray Zone Lymphoma | Cutaneous Lymphoma | Lymphomatoid Papulosis | Cutaneous Anaplastic Large Cell LymphomaUnited States
-
Jiangsu Simcere Biologics Co., LtdRecruitingAdvanced Solid Tumor | Cutaneous T Cell LymphomaChina
-
NYU Langone HealthTerminatedCutaneous T Cell LymphomaUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Yale UniversityCompleted
-
miRagen Therapeutics, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)United States
-
Stanford UniversityCompletedLymphoma, Non-Hodgkin | Mycoses | Lymphoma, T-Cell, Cutaneous | Sezary Syndrome | Cutaneous T-cell Lymphoma | Bone Marrow Transplant FailureUnited States
-
Vanderbilt UniversityCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma | Recurrent Cutaneous T-cell...United States
-
Merck Sharp & Dohme LLCCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
-
Ellen Kim, MDSoligenixRecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
University of PittsburghCompletedSezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
McGill UniversityUnknownCutaneous T-Cell LymphomaCanada
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterActive, not recruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Recurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma and other conditionsUnited States
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
SoligenixCompleted
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Chronic Lymphocytic Leukemia | Anaplastic Large Cell Lymphoma | Small Lymphocytic Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Aggressive Non-Hodgkin Lymphoma | Enteropathy-Associated... and other conditionsUnited States
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and TechnologyCompletedCutaneous T-Cell Lymphoma, Unspecified | Chronic Graft Versus Host Disease in SkinNorway
-
Neumedicines Inc.National Cancer Institute (NCI)UnknownMycosis Fungoides | Sézary Syndrome | Cutaneous T Cell Lymphoma (CTCL)United States
-
M.D. Anderson Cancer CenterUniversity of Pittsburgh; Rush University Medical Center; Boston Medical Center; Vanderbilt University Medical Center and other collaboratorsCompletedMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkRecruitingCutaneous T Cell Lymphoma | Fungoides Mycosis Sezary SyndromeUnited States
-
Rochester General HospitalTerminatedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
University of PittsburghCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
University of PittsburghCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell LymphomaUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
MillennixUnknownLymphomaUnited States
-
BioCryst PharmaceuticalsCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); NYU Langone Health and other collaboratorsCompleted
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruitingCutaneous T-Cell LymphomaSpain
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Medical College of WisconsinMidwest Athletes Against Childhood CancerNot yet recruitingLymphoma | Leukemia | Hodgkin Disease | CD30-Positive Diffuse Large B-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | CD30+ Pleomorphic Large T-Cell Cutaneous Lymphoma | CD30+ Immunoblastic Large T-Cell Cutaneous LymphomaUnited States
-
Yale UniversityWithdrawnLymphoma, T-Cell, Cutaneous
-
Columbia UniversityMallinckrodt, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
Thomas Jefferson UniversityActelionUnknownMycosis Fungoides | Cutaneous T-cell Lymphoma
-
Assistance Publique - Hôpitaux de ParisUnknown